
Simen’s practice focuses on capital market transactions, general company law and securities law. He has considerable experience with assisting Norwegian and international companies and managers in connection with listing processes on the Oslo Stock Exchange and Euronext Growth. Simen also provides advice on acquisitions of listed companies, public offerings, private placements and other transactions. He has international experience from working with capital market transactions in a leading international law firm.
Chambers and Partners and IFLR1000 have ranked Simen as one of Norway’s most prominent experts on stock exchange and securities law. He is also ranked as one of Norway’s leading lawyers on share issues and stock exchange listings in the Norwegian Financial Daily’s annual lawyers survey.
Awards, Work experience, Memberships and Education
- Band 3, Chambers Global, Capital Markets: Equity, 2025
- Promising talents, Advokatundersøkelsen, Finansavisen, Share issues and IPOs, 2024
- Band 3, Chambers Europe, Capital Markets: Equity, 2024
- Band 3, Chambers Global, Capital Markets: Equity, 2024
- Band 3, Chambers Global, Capital Markets: Equity, 2023
- Band 3, Chambers Europe, Capital Markets: Equity, 2023
- Highly regarded, IFLR1000, Capital markets and M&A, 2023
- Top 10, Advokatundersøkelsen, Finansavisen, Issuance and IPOs, 2023
- Band 3, Chambers Global, Capital Markets: Equity Norway, 2022
- Band 3, Chambers Global, Capital Markets: Equity Norway, 2021
- Highly regarded, IFLR1000, M&A, 2019
- Up and coming, Champers Europe, Capital Markets, 2019
- Partner, Wiersholm, 2013
- Secondment, Latham & Watkins, 2011
- Lawyer, Wiersholm, 2005
- Higher Executive Officer, Ministry of Finance, 2003
- Cand. Jur., University of Oslo, 2002
- Partial studies, University of New South Wales, 2002
Selected projects
Assisted the Altrad Group on its acquisition of Beerenberg AS, a company listed on Euronext Growth Oslo.
Assistance to Pronova Biopharma, a company listed on Oslo Stock Exchange, in connection with the voluntary offer from BASF
Assisted on private placement and listing of Norse Atlantic on Euronext Growth.
Assisted Morrow Bank on its IPO and listing on Oslo Børs and subsequent private placements.
Assistance to Marlin Equity Partners on the voluntary offer to acuire shares in Meltwater N.V, a company listed on Oslo Stock Exchange
Assisted Arctic Bioscience AS on its MNOK 300 private placement and listing on Euronext Growth Oslo
Assisted Nordax Bank, owned by Nordic Capital Fund VIII and Sampo, on its NOK 19.6 billion acquisition of Bank Norwegian ASA. The transaction was one of the largest public-to-private acquisitions ever in Norway.
Assisted LNS Mining and Rana Gruber on MNOK 925 secondary sale of shares and listing on Euronext Growth Oslo and subsequent uplisting Oslo Børs.
Assisted Kongsberg Automotive, a company listed on the Oslo Børs, in connection with its MNOK 700 private placement followed by a MNOK 300 subsequent public offering
Assisted Nordic Capital in connection with acquisition of Vizrt Ltd. listed on Oslo Børs through cross border reverse triangular merger.
Assisted Bayer Group on its NOK 17.6 billion acquisition of Algeta ASA, a company listed on Oslo Stock Exchange
Assistance to Hurtigruten, a company listed on Oslo Børs, in connection with the takeover offer from TDR Capital.